Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension

Long‐term efficacy and safety of adjunctive perampanel in patients from the Asia‐Pacific region with refractory focal‐onset seizures in Study 335 open‐label extension

Abstract Objective To evaluate the long‐term efficacy, safety, and tolerability of adjunctive perampanel for the treatment of patients with refractory focal‐onset seizures (FOS), with or without focal to bilateral tonic–clonic seizures (FBTCS), from the Asia‐Pacific region. Methods Study 335 (NCT016...

Full description

Bibliographic Details
Main Authors: Takuji Nishida, Sang Kun Lee, Yushi Inoue, Kazunori Saeki, Kohei Ishikawa, Manoj Malhotra, Anna Patten, Sunao Kaneko
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Epilepsia Open
Subjects:
adjunctive
anti‐seizure medications
focal‐onset seizures
perampanel
refractory
Online Access:https://doi.org/10.1002/epi4.12849

Internet

https://doi.org/10.1002/epi4.12849

Similar Items